{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:45:05Z","timestamp":1761929105733},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":234,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2001,5]]},"abstract":"<jats:p>Melarsoprol, an organo\u2010arsenical drug, has been the drug of choice for late\u2010stage trypanosomiasis for 50\u2003years. Because of the lack of alternatives any abatement of this medication will have a dramatic negative impact on the perspectives for patients. As a large number of patients refractory to melarsoprol treatment was recently reported from northern Uganda and northern Angola, we investigated in northern Angola whether interpatient pharmacokinetic differences influence the outcome of melarsoprol treatment. Drug levels were determined by a biological assay in serum and cerebrospinal fluid (CSF) of 22 patients. Nine patients could be successfully treated, eight were refractory and the outcome was unclear or no adequate follow\u2010up information was available for five patients. No differences in the pharmacokinetic parameters (maximum serum concentration <jats:italic>C<\/jats:italic><jats:sub>max<\/jats:sub>, half\u2010life <jats:italic>t<\/jats:italic><jats:sub>1\/2\u03b2<\/jats:sub>, total clearance <jats:italic>C<\/jats:italic><jats:sub>L<\/jats:sub> and the volume of distribution <jats:italic>V<\/jats:italic><jats:sub>ss<\/jats:sub>) could be detected between the groups. Serum and CSF concentrations for all patients were in the expected range. This result indicates that other underlying factors are responsible for treatment failures.<\/jats:p>","DOI":"10.1046\/j.1365-3156.2001.00725.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T21:37:30Z","timestamp":1047505050000},"page":"412-420","source":"Crossref","is-referenced-by-count":51,"title":["Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment"],"prefix":"10.1111","volume":"6","author":[{"given":"C.","family":"Burri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.1998.00327.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000239130"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/361173a0"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00937118","article-title":"Sexual compatibility among Trypanosoma brucei isolates from an epidemic area in southeastern Uganda","volume":"81","author":"Degen R","year":"1995","journal-title":"Parasitology Research"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(92)90023-D"},{"key":"e_1_2_6_7_2","unstructured":"HeinzelG WoloszczakR ThomannP(1993)TOPFIT \u2013 Pharmacokinetic and Pharmacodynamic Data Analysis System. Gustav Fischer\u2010Verlag Stuttgart."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(99)90151-7"},{"key":"e_1_2_6_9_2","first-page":"171","article-title":"Therapeutic failure of melarsoprol among patients treated for late stage of T.b. gambiense human African trypanosomiasis in Uganda","volume":"92","author":"Legros D","year":"1999","journal-title":"Bulletin de la Soci\u00e9t\u00e9 de Pathologie Exotique"},{"key":"e_1_2_6_10_2","first-page":"169","article-title":"A card agglutination test with stained trypanosomes (CATT) for the serological diagnosis of T.b. gambiense trypanosomiasis","volume":"58","author":"Magnus E","year":"1978","journal-title":"Annales de la Soci\u00e9t\u00e9 Belge de M\u00e9dicine Tropicale"},{"key":"e_1_2_6_11_2","first-page":"113","article-title":"The mechanisms of drug resistance in Trypanosoma brucei spp","volume":"2","author":"Maser P","year":"1997","journal-title":"Recent Research Developments in Antimicrobial Agents and Chemotherapy"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5425.242"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(99)00080-7"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0169-4758(99)01590-2"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-308X(08)60410-8"},{"key":"e_1_2_6_16_2","unstructured":"RowlandM&TozerTN(1989)Clinical Pharmacokinetics. Lea & Febiger Philadelphia."},{"key":"e_1_2_6_17_2","first-page":"481","article-title":"Follow\u2010up des traitements contre la trypanosomiase exp\u00e9riment\u00e9\u00e0 Kimpangu (R\u00e9publique du Zaire)","volume":"57","author":"Ruppol JF","year":"1977","journal-title":"Annales de la Soci\u00e9t\u00e9 Belge de M\u00e9dicine Tropicale"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.bmb.a011692"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(96)90232-1"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(84)90302-7"},{"key":"e_1_2_6_21_2","unstructured":"WHO(1986)Epidemiology and control of African trypanosomiasis.WHO Technical Report Series739 WHO Geneva."},{"key":"e_1_2_6_22_2","unstructured":"WHO(1998)Control and surveillance of African trypanosomiasis.WHO Technical Report Series881 WHO Geneva."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20051825"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-3156.2001.00725.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3156.2001.00725.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T18:17:58Z","timestamp":1697566678000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-3156.2001.00725.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1046\/j.1365-3156.2001.00725.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-3156.2001.00725.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}